This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Emend (Aprepitant) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (205)
Death (31)
Life Threatening Events (24)
Disability (2)
Reports by Reaction Type
Nausea (24),
Dyspnoea (18),
Encephalopathy (18),
Drug Interaction (16),
Renal Failure Acute (14),
Vomiting (9),
Convulsion (9),
Dehydration (9),
Neutropenia (9),
Septic Shock (9),
Dermatitis Bullous (8),
Renal Failure (8)
Below are a few examples of reports where side effects / adverse reactions may be related to Emend (Aprepitant). For a complete list or a specific selection of reports, please use the links above.
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-27
Patient:
Reactions: Drug Hypersensitivity
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Infusion Related Reaction, Infusion Site Erythema
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Headache
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient:
Reactions: Cardio-Respiratory Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-02-21
End date: 2012-02-21
Emend
Dosage: 80 mg, once
Administration route: Oral
Start date: 2012-02-22
End date: 2012-02-22
Etoposide
Dosage: 200 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 160 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 60 mg, once
Start date: 2012-02-21
End date: 2012-02-21
Ondansetron
Dosage: 8 mg, once
Start date: 2012-02-21
End date: 2012-02-21
Ondansetron
Dosage: 8 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Other drugs received by patient: Bicnu; Diamicron; Pravastatin Sodium; Amlodipine; Valium; Nexium; Tramadol HCL; Acetaminophen
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Incorrect Route of Drug Administration, NO Adverse Event
Drug(s) suspected as cause:
Emend
Dosage: unk
Indication: Nausea
Start date: 2012-08-09
Emend
Indication: Vomiting
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Capsule Physical Issue, NO Adverse Event, Drug Administration Error
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Stomatitis, Anaemia, Febrile Neutropenia, Constipation, Neutrophil Count Decreased
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-10-26
End date: 2010-10-26
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-12-07
End date: 2010-12-07
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-11-16
End date: 2010-11-16
Cyclophosphamide
Dosage: 700 mg, once
Indication: Breast Cancer
Start date: 2010-09-29
End date: 2010-10-29
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-10-27
End date: 2010-10-28
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-12-07
End date: 2010-12-07
Emend
Dosage: 125 mg, once
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2010-09-29
End date: 2010-09-29
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-10-26
End date: 2010-10-26
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-09-30
End date: 2010-10-01
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-12-08
End date: 2010-12-09
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-11-17
End date: 2010-11-18
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-11-16
End date: 2010-11-16
Epirubicin Hydrochloride
Dosage: |100 mg, once
Indication: Breast Cancer
Start date: 2010-09-29
End date: 2010-09-29
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-12-07
End date: 2010-12-07
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-10-26
End date: 2010-10-26
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-11-16
End date: 2010-11-16
Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Granisetron Hydrochloride; Mucosta; Mucosta; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate
Possible Emend side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Drug Ineffective, Nausea
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Carboplatin; Compazine; Gemzar
Possible Emend side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Adverse Event
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Cerebrovascular Accident
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Dyspnoea, Chest Pain
Drug(s) suspected as cause:
Emend
Dosage: 150 mg, once
Start date: 2012-05-03
Emend
Dosage: 150 mg, once
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-05-24
Other drugs received by patient: Taxol; Taxol; Cisplatin; Cisplatin
Possible Emend side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Convulsion
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Dexamethasone; TAC; Zofran
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-22
Patient:
Reactions: Infusion Site Pain
Drug(s) suspected as cause:
Emend
Possible Emend side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
Emend
Possible Emend side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14
Patient: 67 year old male
Reactions: Electrocardiogram QT Prolonged, Cardio-Respiratory Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, single
Indication: B-Cell Lymphoma
Start date: 2012-02-22
End date: 2012-02-22
Emend
Dosage: 80 mg, 1x/day
Administration route: Oral
Indication: Premedication
Start date: 2012-02-21
End date: 2012-02-22
Etoposide
Dosage: 100 mg/m2, single
Indication: B-Cell Lymphoma
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 160 mg, 1x/day
Indication: Premedication
Start date: 2012-02-21
End date: 2012-02-22
Ondansetron
Dosage: 8 mg, 1x/day
Indication: Premedication
Start date: 2012-02-21
End date: 2012-02-22
Other drugs received by patient: Diamicron; Amlodipine; Acetaminophen; Bicnu; Nexium; Pravastatin; Valium; Tramadol HCL
Possible Emend side effects in
Reported by a consumer/non-health professional from United States on 2012-08-14
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Ondansetron; Adriamycin PFS; Dexamethasone; Dexamethasone; Cisplatin
Possible Emend side effects in 50 year old male
Reported by a physician from Japan on 2012-08-13
Patient: 50 year old male
Reactions: Schizophrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron Phosphate
Dosage: dosage is uncertain.
Indication: Product Used FOR Unknown Indication
Emend
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Herbal Nerve Tonic Liquid
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Magnesium Oxide
Dosage: dosage is uncertain, drug reported as : ju-kama
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Oxaliplatin
Dosage: dosage is uncertain.
Indication: Large Intestine Carcinoma
Xeloda
Administration route: Oral
Indication: Large Intestine Carcinoma
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-08-10
Patient:
Reactions: Vomiting, Nausea
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Emend
Administration route: Oral
Indication: Nausea
Emend
Indication: Vomiting
Possible Emend side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Chest Discomfort, Paraesthesia Oral, Nausea, Tachycardia, Erythema, Anxiety, Feeling Hot, Infusion Related Reaction
Drug(s) suspected as cause:
Emend
Dosage: 150mg in 145ml of ns once iv
Indication: Bladder Adenocarcinoma Stage Unspecified
Start date: 2012-08-06
End date: 2012-08-06
Emend
Dosage: 150mg in 145ml of ns once iv
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-08-06
End date: 2012-08-06
Other drugs received by patient: NS; Potassium; Magnesium
Possible Emend side effects in
Reported by a physician from Czech Republic on 2012-08-07
Patient:
Reactions: Acute Psychosis
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Ifosfamide; Corticosteroids (Unspecified)
Possible Emend side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female, weighing 54.5 kg (119.9 pounds)
Reactions: Off Label Use, Cerebrovascular Accident, Disability
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Dronabinol
Indication: Impaired Gastric Emptying
Dronabinol
Indication: Nausea
Start date: 2008-01-01
Dronabinol
Indication: Vomiting
Emend
Indication: Nausea
Emend
Indication: Impaired Gastric Emptying
Emend
Indication: Vomiting
Start date: 2008-01-01
Possible Emend side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-03
Patient: female, weighing 54.5 kg (119.9 pounds)
Reactions: Off Label Use, Cerebrovascular Accident, Disability
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Dronabinol
Indication: Impaired Gastric Emptying
Dronabinol
Indication: Nausea
Start date: 2008-01-01
Dronabinol
Indication: Vomiting
Emend
Indication: Vomiting
Emend
Indication: Impaired Gastric Emptying
Emend
Indication: Nausea
Start date: 2008-01-01
Possible Emend side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient:
Reactions: Pain in Extremity, Infusion Site Pain, Infusion Site Rash, Infusion Site Pruritus
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Doxorubicin Hydrochloride
Possible Emend side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient:
Reactions: Pain in Extremity, Infusion Site Pain, Infusion Site Rash, Infusion Site Pruritus
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Doxorubicin Hydrochloride
Possible Emend side effects in
Reported by a physician from Czech Republic on 2012-08-01
Patient:
Reactions: Acute Psychosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Emend
Dosage: 125 mg, once
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-20
Emend
Dosage: 80 mg, once
Administration route: Oral
Start date: 2012-06-21
Emend
Dosage: 80 mg, once
Administration route: Oral
Start date: 2012-06-22
Other drugs received by patient: Doxorubicin Hydrochloride; Mesna; Mesna; Fraxiparine; Dexona Injection; Metoprolol Tartrate; Fraxiparine; Corticosteroids (Unspecified); Oxycontin; Ondansetron; Cordarone; Potassium Chloride; Mesna; Ifosfamide
Possible Emend side effects in
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient:
Reactions: Pain in Extremity, Infusion Site Pain, Infusion Site Rash, Infusion Site Pruritus
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Doxorubicin Hydrochloride
Possible Emend side effects in
Reported by a physician from France on 2012-08-01
Patient:
Reactions: Renal Failure, Lung Disorder, Toxic Encephalopathy, Drug Interaction, Pancytopenia, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Emend
Other drugs received by patient possibly interacting with the suspect drug: Cyclophosphamide
Dosage: unk
Indication: Sarcoma
Start date: 2012-03-22
Cyclophosphamide
Dosage: unk
Start date: 2012-04-23
Cyclophosphamide
Dosage: unk
Other drugs received by patient: Calciparine; Granocyte; Zofran
Possible Emend side effects in
Reported by a physician from Czech Republic on 2012-07-31
Patient:
Reactions: Acute Psychosis
Drug(s) suspected as cause:
Emend
Other drugs received by patient: Corticosteroids (Unspecified)
Possible Emend side effects in
Reported by a pharmacist from United States on 2012-07-31
Patient:
Reactions: Pain, Adverse Event, Skin Burning Sensation
Drug(s) suspected as cause:
Emend
|